<DOC>
	<DOCNO>NCT01764269</DOCNO>
	<brief_summary>In study , investigator prospectively assess fever rate 24-59 month old patient day 0-10 administration inactivate influenza vaccine ( IIV ) live attenuate influenza vaccine ( LAIV ) . Children one three study site receive vaccine part routine care enroll study parent ability receive send text message . Children enrol study observe eleven day period start day vaccine administration via series text message parent .</brief_summary>
	<brief_title>Assessing Fever Rates Children Ages 24 59 Months After Live Attenuated Influenza Vaccine ( LAIV ) Inactivated Influenza Vaccines ( IIV ) Using Text Messaging U.S . Influenza Vaccines 2012-2013 &amp; 2013-2014</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1. 24 59 month age , 2. visit study site anytime study period , 3. receive first dose LAIV IIV season , 4. parent cell phone text messaging capability , 5. parent speaks English Spanish . Exclusion criterion : 1. chronic medical condition child precludes receipt LAIV ( except history asthma wheeze episode within past 12 month note medical record ) , 2. currently oral systemic steroid use past month , 3. currently inhale steroid use past 2 week , 4. presence fever &gt; =100.4 time vaccination , 5. administration antipyretic 6hour period prior vaccination , 6. state intent , time vaccination , use prophylactic antipyretic development fever , 7. parent speaks language English Spanish , 8. parent 's inability read text message , 9. child receive second dose influenza vaccine current season .</criteria>
	<gender>All</gender>
	<minimum_age>24 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>